164 related articles for article (PubMed ID: 18224333)
1. The effect of AMPD1 genotype on blood flow response to sprint exercise.
Norman B; Nygren AT; Nowak J; Sabina RL
Eur J Appl Physiol; 2008 May; 103(2):173-80. PubMed ID: 18224333
[TBL] [Abstract][Full Text] [Related]
2. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
[TBL] [Abstract][Full Text] [Related]
3. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.
Norman B; Sabina RL; Jansson E
J Appl Physiol (1985); 2001 Jul; 91(1):258-64. PubMed ID: 11408438
[TBL] [Abstract][Full Text] [Related]
4. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
[TBL] [Abstract][Full Text] [Related]
5. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
[TBL] [Abstract][Full Text] [Related]
6. AMPD1 rs17602729 is associated with physical performance of sprint and power in elite Lithuanian athletes.
Ginevičienė V; Jakaitienė A; Pranculis A; Milašius K; Tubelis L; Utkus A
BMC Genet; 2014 May; 15():58. PubMed ID: 24885427
[TBL] [Abstract][Full Text] [Related]
7. Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.
Rannou F; Scotet V; Marcorelles P; Monnoyer R; Le Maréchal C
PLoS One; 2017; 12(11):e0187266. PubMed ID: 29095874
[TBL] [Abstract][Full Text] [Related]
8. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle.
Norman B; Mahnke-Zizelman DK; Vallis A; Sabina RL
J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316
[TBL] [Abstract][Full Text] [Related]
9. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.
Rico-Sanz J; Rankinen T; Joanisse DR; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C;
Physiol Genomics; 2003 Jul; 14(2):161-6. PubMed ID: 12783984
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle contraction kinetics and AMPK responses are modulated by the adenine nucleotide degrading enzyme AMPD1.
Hafen PS; Law AS; Matias C; Miller SG; Brault JJ
J Appl Physiol (1985); 2022 Nov; 133(5):1055-1066. PubMed ID: 36107988
[TBL] [Abstract][Full Text] [Related]
11. Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient.
Abe M; Higuchi I; Morisaki H; Morisaki T; Osame M
Neuromuscul Disord; 2000 Oct; 10(7):472-7. PubMed ID: 10996775
[TBL] [Abstract][Full Text] [Related]
12.
Leońska-Duniec A; Maculewicz E; Humińska-Lisowska K; Maciejewska-Skrendo A; Leźnicka K; Cięszczyk P; Sawczuk M; Trybek G; Wilk M; Lepionka W; Ficek K
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32429460
[TBL] [Abstract][Full Text] [Related]
13. AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.
Hanisch F; Joshi P; Zierz S
J Neurol; 2008 Mar; 255(3):318-22. PubMed ID: 18338202
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the myoadenylate deaminase deficiencies.
Sabina RL; Fishbein WN; Pezeshkpour G; Clarke PR; Holmes EW
Neurology; 1992 Jan; 42(1):170-9. PubMed ID: 1370861
[TBL] [Abstract][Full Text] [Related]
15. AMPD1 gene polymorphism and the vasodilatory response to ischemia.
Hand BD; Roth SM; Roltsch MH; Park JJ; Kostek MC; Ferrell RE; Brown MD
Life Sci; 2006 Sep; 79(15):1413-8. PubMed ID: 16707139
[TBL] [Abstract][Full Text] [Related]
16. Muscle blood flow at onset of dynamic exercise in humans.
Rådegran G; Saltin B
Am J Physiol; 1998 Jan; 274(1):H314-22. PubMed ID: 9458882
[TBL] [Abstract][Full Text] [Related]
17. Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene.
Riksen NP; Franke B; Oyen WJ; Borm GF; van den Broek P; Boerman OC; Smits P; Rongen GA
Eur Heart J; 2007 May; 28(9):1085-91. PubMed ID: 17376785
[TBL] [Abstract][Full Text] [Related]
18. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle.
Hanisch F; Hellsten Y; Zierz S
Biol Chem; 2006 Jan; 387(1):53-8. PubMed ID: 16497164
[TBL] [Abstract][Full Text] [Related]
19. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Safranow K; Czyzycka E; Binczak-Kuleta A; Rzeuski R; Skowronek J; Wojtarowicz A; Jakubowska K; Olszewska M; Loniewska B; Kaliszczak R; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
Scand J Clin Lab Invest; 2009; 69(1):102-12. PubMed ID: 18855224
[TBL] [Abstract][Full Text] [Related]
20. Effect of AMPD1 gene polymorphism on muscle activity in humans.
Fedotovskaya ON; Danilova AA; Akhmetov II
Bull Exp Biol Med; 2013 Feb; 154(4):489-91. PubMed ID: 23486588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]